226 related articles for article (PubMed ID: 17132419)
1. Changes in insulin sensitivity in morbidly obese patients with or without metabolic syndrome after gastric bypass.
Coppini LZ; Bertevello PL; Gama-Rodrigues J; Waitzberg DL
Obes Surg; 2006 Nov; 16(11):1520-5. PubMed ID: 17132419
[TBL] [Abstract][Full Text] [Related]
2. Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass.
Rossi M; Serpa Neto A; Rossi FM; Amarante RD; Alcântara GC; da Silva RB; Regina PF
Surg Obes Relat Dis; 2009; 5(1):11-8. PubMed ID: 18996755
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
[TBL] [Abstract][Full Text] [Related]
4. Decrease in circulating glucose, insulin and leptin levels and improvement in insulin resistance at 1 and 3 months after gastric bypass.
Ramos AP; de Abreu MR; Vendramini RC; Brunetti IL; Pepato MT
Obes Surg; 2006 Oct; 16(10):1359-64. PubMed ID: 17059747
[TBL] [Abstract][Full Text] [Related]
5. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
6. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of weight loss on insulin resistance in surgically treated obese patients.
Muscelli E; Mingrone G; Camastra S; Manco M; Pereira JA; Pareja JC; Ferrannini E
Am J Med; 2005 Jan; 118(1):51-7. PubMed ID: 15639210
[TBL] [Abstract][Full Text] [Related]
8. Effects of obesity surgery on the metabolic syndrome.
Lee WJ; Huang MT; Wang W; Lin CM; Chen TC; Lai IR
Arch Surg; 2004 Oct; 139(10):1088-92. PubMed ID: 15492149
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.
Tajtákova M; Petrásova D; Petrovicová J; Pytliak M; Semanová Z
Endocr Regul; 2006 Mar; 40(1):15-9. PubMed ID: 16964963
[TBL] [Abstract][Full Text] [Related]
10. HOMA, QUICKI and MFfm to measure insulin resistance in morbid obesity.
Ruano M; Silvestre V; Castro R; García-Lescún MC; Aguirregoicoa E; Marco A; Rodríguez A; García-Blanch G
Obes Surg; 2006 May; 16(5):549-53. PubMed ID: 16687020
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome: yet another co-morbidity gastric bypass helps cure.
Madan AK; Orth W; Ternovits CA; Tichansky DS
Surg Obes Relat Dis; 2006; 2(1):48-51; discussion 51. PubMed ID: 16925317
[TBL] [Abstract][Full Text] [Related]
12. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
[TBL] [Abstract][Full Text] [Related]
13. Morbid obesity and gastric bypass surgery: biochemical profile.
Silvestre V; Ruano M; Domínguez Y; Castro R; García-Lescun MC; Rodríguez A; Marco A; García-Blanch G
Obes Surg; 2004 Oct; 14(9):1227-32. PubMed ID: 15527639
[TBL] [Abstract][Full Text] [Related]
14. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
[TBL] [Abstract][Full Text] [Related]
15. Detailed description of early response of metabolic syndrome after laparoscopic Roux-en-Y gastric bypass.
Ali MR; Fuller WD; Rasmussen J
Surg Obes Relat Dis; 2009; 5(3):346-51. PubMed ID: 19362060
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.
Iannelli A; Anty R; Schneck AS; Tran A; Gugenheim J
Surgery; 2011 Mar; 149(3):364-70. PubMed ID: 20932542
[TBL] [Abstract][Full Text] [Related]
17. Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: similar body weight loss, correction of comorbidities, and improvement of quality of life.
Suter M; Calmes JM; Paroz A; Romy S; Giusti V
Arch Surg; 2009 Apr; 144(4):312-8; discussion 318. PubMed ID: 19380643
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
[TBL] [Abstract][Full Text] [Related]
19. Mild elevation of fasting plasma glucose is a strong risk factor for postoperative complications in gastric bypass patients.
Czupryniak L; Strzelczyk J; Pawlowski M; Loba J
Obes Surg; 2004; 14(10):1393-7. PubMed ID: 15603657
[TBL] [Abstract][Full Text] [Related]
20. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
